Robeco Institutional Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.8M | Sell |
545,135
-221,297
| -29% | -$12.9M | 0.04% | 297 |
|
|
2025
Q4 | $45.5M | Sell |
766,432
-169,034
| -18% | -$9.2M | 0.06% | 256 |
|
|
2025
Q3 | $50.7M | Buy |
935,466
+293,748
| +46% | +$16.8M | 0.07% | 234 |
|
|
2025
Q2 | $35.3M | Buy |
641,718
+544,457
| +560% | +$32.1M | 0.06% | 269 |
|
|
2025
Q1 | $6.88M | Buy |
97,261
+10,687
| +12% | +$719K | 0.01% | 490 |
|
|
2024
Q4 | $5.69M | Sell |
86,574
-124,092
| -59% | -$8.31M | 0.01% | 527 |
|
|
2024
Q3 | $14.8M | Buy |
210,666
+128,807
| +157% | +$10.8M | 0.03% | 381 |
|
|
2024
Q2 | $6.74M | Buy |
81,859
+26,481
| +48% | +$2.2M | 0.01% | 486 |
|
|
2024
Q1 | $4.84M | Buy |
55,378
+41,381
| +296% | +$3.7M | 0.01% | 554 |
|
|
2023
Q4 | $1.35M | Sell |
13,997
-11,170
| -44% | -$988K | ﹤0.01% | 752 |
|
|
2023
Q3 | $2.23M | Sell |
25,167
-3,043
| -11% | -$271K | 0.01% | 665 |
|
|
2023
Q2 | $2.45M | Sell |
28,210
-6,695
| -19% | -$630K | 0.01% | 661 |
|
|
2023
Q1 | $3.39M | Buy |
34,905
+4,640
| +15% | +$481K | 0.01% | 621 |
|
|
2022
Q4 | $3.13M | Sell |
30,265
-27,269
| -47% | -$2.56M | 0.01% | 643 |
|
|
2022
Q3 | $4.88M | Buy |
57,534
+3,842
| +7% | +$342K | 0.02% | 519 |
|
|
2022
Q2 | $4.45M | Buy |
53,692
+3,960
| +8% | +$315K | 0.01% | 528 |
|
|
2022
Q1 | $3.83M | Buy |
49,732
+46,705
| +1,543% | +$3.91M | 0.01% | 583 |
|
|
2021
Q4 | $268K | Buy |
3,027
+33
| +1% | +$2.72K | ﹤0.01% | 817 |
|
|
2021
Q3 | $231K | Sell |
2,994
-5,158
| -63% | -$407K | ﹤0.01% | 835 |
|
|
2021
Q2 | $680K | Sell |
8,152
-5,173
| -39% | -$410K | ﹤0.01% | 774 |
|
|
2021
Q1 | $1M | Sell |
13,325
-13,332
| -50% | -$1.09M | ﹤0.01% | 730 |
|
|
2020
Q4 | $2.34M | Sell |
26,657
-20,937
| -44% | -$1.66M | 0.01% | 645 |
|
|
2020
Q3 | $3.62M | Sell |
47,594
-10,956
| -19% | -$1.11M | 0.01% | 560 |
|
|
2020
Q2 | $7.22M | Buy |
58,550
+54,605
| +1,384% | +$5.43M | 0.02% | 470 |
|
|
2020
Q1 | $333K | Buy |
3,945
+140
| +4% | +$12.1K | ﹤0.01% | 844 |
|
|
2019
Q4 | $321K | Sell |
3,805
-3,164
| -45% | -$239K | ﹤0.01% | 873 |
|
|
2019
Q3 | $469K | Buy |
6,969
+2,243
| +47% | +$173K | ﹤0.01% | 844 |
|
|
2019
Q2 | $405K | Hold |
4,726
| – | – | ﹤0.01% | 864 |
|
|
2019
Q1 | $419K | Buy |
4,726
+1,562
| +49% | +$145K | ﹤0.01% | 856 |
|
|
2018
Q4 | $269K | Hold |
3,164
| – | – | ﹤0.01% | 870 |
|
|
2018
Q3 | $307K | Hold |
3,164
| – | – | ﹤0.01% | 867 |
|
|
2018
Q2 | $298K | Hold |
3,164
| – | – | ﹤0.01% | 866 |
|
|
2018
Q1 | $257K | Hold |
3,164
| – | – | ﹤0.01% | 872 |
|
|
2017
Q4 | $282K | Buy |
+3,164
| New | +$275K | ﹤0.01% | 812 |
|
|
2016
Q4 | – | Sell |
-5,539
| Closed | -$512K | – | 807 |
|
|
2016
Q3 | $512K | Hold |
5,539
| – | – | ﹤0.01% | 700 |
|
|
2016
Q2 | $431K | Hold |
5,539
| – | – | ﹤0.01% | 705 |
|
|
2016
Q1 | $457K | Hold |
5,539
| – | – | ﹤0.01% | 704 |
|
|
2015
Q4 | $580K | Hold |
5,539
| – | – | 0.01% | 663 |
|
|
2015
Q3 | $583K | Hold |
5,539
| – | – | ﹤0.01% | 616 |
|
|
2015
Q2 | $758K | Buy |
5,539
+1,335
| +32% | +$165K | 0.01% | 608 |
|
|
2015
Q1 | $524K | Hold |
4,204
| – | – | ﹤0.01% | 631 |
|
|
2014
Q4 | $380K | Buy |
4,204
+1,525
| +57% | +$127K | ﹤0.01% | 673 |
|
|
2014
Q3 | $193K | Buy |
+2,679
| New | +$176K | ﹤0.01% | 677 |
|
|
2014
Q2 | – | Sell |
-775
| Closed | -$53K | – | 755 |
|
|
2014
Q1 | $53K | Hold |
775
| – | – | ﹤0.01% | 697 |
|
|
2013
Q4 | $54K | Hold |
775
| – | – | ﹤0.01% | 622 |
|
|
2013
Q3 | $56K | Hold |
775
| – | – | ﹤0.01% | 609 |
|
|
2013
Q2 | $43K | Buy |
+775
| New | +$48.3K | ﹤0.01% | 622 |
|
Other funds holding BMRN
VCM
VPM
